Aberdeen Asset Management PLC UK raised its position in shares of CME Group Inc. (NASDAQ:CME) by 1.5% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 639,993 shares of the company’s stock after buying an additional 9,408 shares during the period. Aberdeen Asset Management PLC UK’s holdings in CME Group were worth $62,335,000 at the end of the most recent reporting period.
A number of other hedge funds have also bought and sold shares of CME. Franklin Resources Inc. purchased a new stake in shares of CME Group during the first quarter worth $222,000. Rafferty Asset Management LLC boosted its stake in shares of CME Group by 49.3% in the first quarter. Rafferty Asset Management LLC now owns 42,301 shares of the company’s stock worth $4,063,000 after buying an additional 13,960 shares during the last quarter. Edmond DE Rothschild Holding S.A. purchased a new stake in shares of CME Group during the first quarter worth $420,000. Primecap Management Co. CA boosted its stake in shares of CME Group by 6.5% in the first quarter. Primecap Management Co. CA now owns 1,946,113 shares of the company’s stock worth $186,924,000 after buying an additional 118,150 shares during the last quarter. Finally, Pictet Asset Management Ltd. boosted its stake in shares of CME Group by 0.9% in the first quarter. Pictet Asset Management Ltd. now owns 173,447 shares of the company’s stock worth $15,860,000 after buying an additional 1,590 shares during the last quarter. Hedge funds and other institutional investors own 79.89% of the company’s stock.
Shares of CME Group Inc. (NASDAQ:CME) traded up 0.03% during midday trading on Wednesday, reaching $104.12. 229,118 shares of the company’s stock traded hands. CME Group Inc. has a 52-week low of $81.87 and a 52-week high of $110.35. The stock has a 50 day moving average of $106.33 and a 200-day moving average of $99.87. The stock has a market cap of $35.28 billion, a price-to-earnings ratio of 26.29 and a beta of 0.83.
CME Group (NASDAQ:CME) last announced its quarterly earnings results on Thursday, July 28th. The company reported $1.14 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.11 by $0.03. CME Group had a return on equity of 6.83% and a net margin of 38.22%. The business earned $906 million during the quarter, compared to the consensus estimate of $897.84 million. During the same quarter last year, the firm posted $0.95 EPS. The company’s quarterly revenue was up 10.5% on a year-over-year basis. On average, equities research analysts expect that CME Group Inc. will post $4.43 EPS for the current year.
The firm also recently declared a quarterly dividend, which was paid on Monday, September 26th. Shareholders of record on Friday, September 9th were issued a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a yield of 2.31%. The ex-dividend date of this dividend was Wednesday, September 7th. CME Group’s dividend payout ratio is 60.61%.
A number of analysts have recently weighed in on the stock. JPMorgan Chase & Co. set a $116.00 price objective on shares of CME Group and gave the stock a “buy” rating in a research note on Monday, September 12th. Jefferies Group upped their target price on shares of CME Group from $112.00 to $118.00 and gave the company a “buy” rating in a research note on Wednesday, August 31st. Zacks Investment Research cut shares of CME Group from a “buy” rating to a “hold” rating in a research note on Wednesday, September 7th. Deutsche Bank AG upped their target price on shares of CME Group from $115.00 to $116.00 and gave the company a “buy” rating in a research note on Wednesday, October 5th. Finally, Keefe, Bruyette & Woods upped their target price on shares of CME Group from $99.00 to $103.00 and gave the company a “market perform” rating in a research note on Friday, July 29th. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and five have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $103.27.
In other news, insider Bryan T. Durkin sold 15,000 shares of CME Group stock in a transaction on Tuesday, September 6th. The stock was sold at an average price of $107.75, for a total transaction of $1,616,250.00. Following the completion of the sale, the insider now owns 63,967 shares of the company’s stock, valued at $6,892,444.25. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Kimberly S. Taylor sold 2,300 shares of CME Group stock in a transaction on Monday, August 1st. The stock was sold at an average price of $102.58, for a total value of $235,934.00. Following the sale, the insider now directly owns 103,789 shares of the company’s stock, valued at approximately $10,646,675.62. The disclosure for this sale can be found here. Company insiders own 0.61% of the company’s stock.
About CME Group
CME Group Inc is a provider of products across all major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. The Company’s products include both exchange-traded and privately negotiated futures and options contracts and swaps. The Company connects buyers and sellers together through its CME Globex electronic trading platform across the globe and its open outcry trading facilities in Chicago and New York City.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.